.jpg)
Why satisfaction scores fail to predict fertility clinic patient loyalty
Satisfaction measures how a patient felt about a specific interaction. Loyalty measures whether a patient returns, continues, and refers. In most consumer contexts, these two things correlate reasonably well. In fertility care, they often don't.
The reason is the emotional complexity of the treatment itself. A patient can have a genuinely positive clinical interaction - a kind nurse, a clear explanation, a well-run appointment - and still leave feeling unsupported in the moments that mattered most to her: the silence after a negative result, the lack of proactive communication during the two-week wait, the sense that no one acknowledged what a failed cycle actually costs.
Research on healthcare loyalty consistently finds that continuity of relationship, not quality of individual interactions, is the strongest predictor of whether patients return and refer. [1] In fertility specifically, where patients often navigate multiple cycles over months or years, loyalty is built in the aggregate - through consistent, milestone-triggered contact that signals the clinic is paying attention even when there is no appointment on the calendar.
What actually drives IVF patient continuation rate
When patients who discontinue fertility treatment are asked why, cost and emotional toll are the most cited reasons. These are real factors. But research by Gameiro et al. found that a third factor - feeling insufficiently supported or informed - appears consistently across discontinuation studies and is the factor most amenable to clinic design. [2]
That finding matters because it shifts the frame. Cost and emotional toll are largely outside a clinic's control. Support and information are not. A clinic that designs deliberately for both will see a measurable difference in its IVF patient continuation rate - not because it changed outcomes, but because it changed how patients experience the space between them.
The specific drivers of continuation that appear most reliably in the research are: proactive communication at clinical milestones, named ownership of each patient relationship, and a clear protocol for what happens after a negative result. These are not soft interventions. They are workflow design choices with measurable revenue implications.
A systematic review of 22 studies on fertility treatment discontinuation identified clinic-related factors - including patients feeling poorly informed and insufficiently supported - as consistent predictors of non-return, alongside cost and emotional burden. Unlike cost, clinic-related factors are directly amenable to design change.
Gameiro S, Boivin J et al. - Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation - Human Reproduction Update - 2012
Reducing IVF cycle abandonment: the protocol changes that move the number
Cycle abandonment - patients who start a treatment cycle and do not complete it, or who complete one cycle and disengage before a planned second - is among the least-tracked metrics in fertility practice management. Most clinics know their cycle start volume. Few can tell you their cycle completion rate or their 90-day re-engagement rate after a negative result.
Measuring these numbers is the first step. The second is understanding which protocol changes actually move them.
The three changes with the strongest evidence base are:
1. A post-failure outreach protocol.
A named contact reaches the patient within four hours of a negative beta, not to discuss next steps clinically, but to acknowledge the result and confirm ongoing support. Clinics with a formal post-failure protocol report meaningfully higher second-cycle rates than those without one. [2]
2. Milestone-triggered communication during active cycles.
Patients in a stimulation or two-week-wait phase who receive proactive updates at defined clinical milestones disengage at lower rates than those who receive reactive communication only. The content matters less than the consistency.
3. A 30-day re-engagement touchpoint.
Patients who do not schedule a follow-up appointment within 30 days of a negative result are at the highest risk of permanent discontinuation. A single outreach at the 30-day mark - not a sales message, a genuine check-in - recovers a meaningful proportion of patients who would otherwise not return.
Where to start this week
Pull your data from the last six months and calculate two numbers: the percentage of patients who returned for a second cycle after a failed first cycle, and the average number of days between a negative result and a next-step appointment. Those two numbers will tell you more about your actual loyalty picture than any satisfaction survey.
Satisfaction is what patients remember about a visit. Loyalty is what they do next. Clinics that build for the second one tend to find the first one follows.
Sources
[1] Doyle C, Lennox L, Bell D - A systematic review of evidence on the links between patient experience and clinical safety and effectiveness - BMJ Open - 2013 - bmjopen.bmj.com
[2] Gameiro S, Boivin J et al. - Why do patients discontinue fertility treatment? A systematic review - Human Reproduction Update - 2012 - academic.oup.com/humupd
.jpg)
